Effects of Topically Instilled Bunazosin, an α<sub>1</sub>-Adrenoceptor Antagonist, on Constrictions Induced by Phenylephrine and ET-1 in Rabbit Retinal Arteries

  • Masaki Ichikawa
    From the Research and Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; the
  • Yuji Okada
    From the Research and Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; the
  • Yuki Asai
    From the Research and Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; the
  • Hideaki Hara
    From the Research and Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan; the2Department of Biofunctional Molecules, Gifu Pharmaceutical University, Gifu, Japan; the
  • Kiyoshi Ishii
    Eye Clinic, Saitama Red Cross Hospital, Saitama, Japan; and the
  • Makoto Araie
    Department of Ophthalmology, Tokyo University School of Medicine, Tokyo, Japan.

収録刊行物

被引用文献 (4)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ